Skip to content
Edition of Thursday, 12 November 2026English edition
The Geopolitician

Country risk, from the local press

Israel · Country watch

Netanyahu-Eisenkot Meeting, Tax Reform, Teva's Shift

Netanyahu and Eisenkot meet over security; tax reform proposals released; Teva shifts focus to biopharma.

The picture Stable How this is judged →

The business environment in Israel remains stable with significant political and regulatory developments. Netanyahu and Eisenkot's meeting clarifies security priorities, while upcoming tax reform recommendations may impact financial planning. Teva's strategic shift to biopharma signals changes in the pharmaceutical sector.

In this briefing Government of Israel · Richard Francis · Teva Pharmaceuticals · Benjamin Netanyahu · Gadi Eisenkot

Regulation

  • Finance
  • Public sector

Tax reform recommendations to be published soon

נשיא המדינה יצחק הרצוג, וראש הממשלה בנימין נתניהו, במרכז התמונה המסורתית במשכן הנשיא בירושלים לרגל השבעת ממשלת ישראל ה-37. יום חמישי, ה' טבת
נשיא המדינה יצחק הרצוג, וראש הממשלה בנימין נתניהו, במרכז התמונה המסורתית במשכן הנשיא בירושלים לרגל השבעת ממשלת ישראל ה-37. יום חמישי, ה' טבת — Avi Ohayon, CC BY-SA 3.0 via Wikimedia Commons

Recommendations for a major tax reform in Israel are set to be published before the formation of a new government, according to cursorinfo. The reforms aim to adjust tax rates and remove certain tax benefits, emphasizing their professional nature. The publication of these recommendations is intended to influence the incoming government's policy decisions.

Impact Taxpayers and financial planners must prepare for potential changes in tax rates and benefits as reforms are outlined.

Sources: cursorinfo ↗

Companies

  • Pharma

Teva CEO outlines shift to biopharma focus

Teva Pharmaceuticals CEO Richard Francis announced that the company is evolving into a biopharma company, with branded drugs expected to account for 25% of its revenue by 2030, up from 9% in 2022, reports Globes. This strategic shift highlights Teva's focus on expanding its branded drug portfolio as part of its long-term growth strategy.

Impact Investors and partners of Teva Pharmaceuticals should anticipate a strategic shift towards branded drugs, affecting revenue streams.

Sources: Globes ↗

Politics

  • Defence
  • Public sector

Netanyahu and Eisenkot hold security briefing

Part of: Political maneuvering in Israel amid coalition talks →

Prime Minister Benjamin Netanyahu and Yashar party chairman Gadi Eisenkot held a two-hour security briefing in Jerusalem. The meeting comes amid tensions over Iran and follows Eisenkot's request for intelligence updates during the government's transition. The two leaders agreed to continue sharing information as needed, according to Ynet. This meeting marks their first since the recent election, highlighting ongoing diplomatic and security challenges.

Impact Defence contractors and public-sector agencies gain clarity on security priorities amid Iran tensions.

Sources: Ynet ↗, Arutz Sheva ↗, Jerusalem Post ↗

Nothing significant reported today in Disruption · Internal tension · Safety & health · Markets · Trade.

Also today in the local press

Sources in this briefing

Sources: each headline links to the original article on the publisher's site.

All Israel briefings →